Catherwood B D, Deftos L J
J Immunol Methods. 1979;31(3-4):315-22. doi: 10.1016/0022-1759(79)90144-3.
We studied reactivity of highly purified pituitary hormones in our human calcitonin (hCT) radioimmunoassay (RIA) which can detect 1 pg of hCT. ACTH at doses of greater than 1 microgram of peptide per RIA tube reacted in the hCT assay, as did beta-endorphin (beta EPH) at a dose of 10 micrograms per tube. No reactivity was observed with comparable concentrations of all other known pituitary hormones. ACTH also reacted at doses greater than 1 microgram per tube with 7 other hCT antisera which recognized differing antigenic determinants in the calcitonin molecule but it was not reactive with 2 antisera against porcine calcitonin or 2 antisera against salmon calcitonin. This slight degree of cross-reactivity of hACTH and beta EPH in the hCT RIA cannot account for the presence of immunoreactive CT in pituitary glands. Nevertheless, antisera used for the localization of peptides must be rigorously tested for the existence of cross-reactivities with other possible substances, especially if such antisera detect the peptide in unexpected tissues.
我们在可检测1皮克人降钙素(hCT)的人降钙素放射免疫分析(RIA)中研究了高纯度垂体激素的反应性。每管放射免疫分析中肽剂量大于1微克的促肾上腺皮质激素(ACTH)在hCT分析中有反应,每管剂量为10微克的β-内啡肽(βEPH)也是如此。在所有其他已知垂体激素的可比浓度下未观察到反应性。每管剂量大于1微克的ACTH与其他7种hCT抗血清也有反应,这些抗血清识别降钙素分子中不同的抗原决定簇,但它与2种抗猪降钙素抗血清或2种抗鲑鱼降钙素抗血清无反应。hACTH和βEPH在hCT RIA中的这种轻微交叉反应程度不能解释垂体中免疫反应性CT的存在。然而,用于肽定位的抗血清必须严格检测与其他可能物质的交叉反应性,特别是如果这种抗血清在意外组织中检测到该肽。